Amgen, Inc. (AMGN)

CrispIdea Report
Published: November 24, 2017

Web Price :

$ 99.00

  • Sources: CrispIdea
  • Format: PDF
  • Language: English

AMGN reported good quarterly results reflecting decreased operating costs and EPS growth. Their cost efficiencies continued for the quarter, even after absorbing the costs of Hurricane Maria. The new brands also continue to show growth in the volumes.

 

Contents
• Executive Summary
• Financial Statements
– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q3FY17 Results – Overview
– Q3FY17 – Product Revenues
– Q3FY17 – R&D Update
– Q3FY17 – FY17 Guidance and Conclusion
• Historical Performance
– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per Share Items and Key Ratios
– Key Cash Flow Items
• Product Performance and Key Developments
– Ownership
– Competition
– Key Developments
• Valuation and Consensus Performance
– Relative Valuation
– Analyst Recommendations
• Market Price Performance